CCM
AMED

Coldstream Capital Management’s Amedisys AMED Stock Holding History

Coldstream Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,252
Closed -$116K – 1205
2025
Q1 		$116K Buy
+1,252
New +$115K ﹤0.01% 1274

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Coldstream Capital Management's AMED Position: Q2 2025 in Review

Coldstream Capital Management sold out of Amedisys (AMED) in Q2 2025, closing a stake of 1,252 shares — an estimated $116K sold.

Coldstream Capital Management first reported a position in AMED in Q1 2025 and held it in 1 quarter. The position peaked at $116K in Q1 2025. 319 funds tracked by Wall St. Rank hold AMED as of Q2 2025.

  • Coldstream Capital Management reported no remaining Amedisys position as of Q2 2025 after selling out during the quarter.
  • Coldstream Capital Management sold 1,252 Amedisys shares in Q2 2025, an estimated $116K.
  • Coldstream Capital Management first reported a position in Amedisys in Q1 2025 and held it in 1 quarter.
  • Coldstream Capital Management's Amedisys position peaked at $116K in Q1 2025.
  • 319 funds tracked by Wall St. Rank held Amedisys as of Q2 2025.

Based on Coldstream Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.